Tuberculosis Research and Treatment

Editorial Board

Academic Editors

  • Nafees Ahmad , Discipline of Clinical Pharmacy School of Pharmaceutical Sciences Universiti Sains Malaysia, Malaysia
  • Alexander S. Apt, Central Institute for Tuberculosis, Russia
  • Karl Drlica, University of Medicine and Dentistry of New Jersey, USA
  • Edward A. Graviss , Department of Pathology and Genomic Medicine, Methodist Hospital Research Institute, USA
  • Juraj Ivanyi , King's College London, United Kingdom
  • Vincent Jarlier, Pitié-Salpêtrière, France
  • Amit Kaushik , Johns Hopkins University, USA
  • José R. Lapa e Silva, Rio de Janeiro Federal University, Brazil
  • Sarman Singh , All India Institute of Medical Sciences, India
    Tuberculosis Research and Treatment
     Journal metrics
    Acceptance rate31%
    Submission to final decision108 days
    Acceptance to publication19 days
    Impact Factor-

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.